MXPA02010064A - Bancos mutantes. - Google Patents

Bancos mutantes.

Info

Publication number
MXPA02010064A
MXPA02010064A MXPA02010064A MXPA02010064A MXPA02010064A MX PA02010064 A MXPA02010064 A MX PA02010064A MX PA02010064 A MXPA02010064 A MX PA02010064A MX PA02010064 A MXPA02010064 A MX PA02010064A MX PA02010064 A MXPA02010064 A MX PA02010064A
Authority
MX
Mexico
Prior art keywords
mutant
mutant bank
bank
relates
disrupts
Prior art date
Application number
MXPA02010064A
Other languages
English (en)
Inventor
Mike Birch
Original Assignee
F2G Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F2G Ltd filed Critical F2G Ltd
Publication of MXPA02010064A publication Critical patent/MXPA02010064A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1082—Preparation or screening gene libraries by chromosomal integration of polynucleotide sequences, HR-, site-specific-recombination, transposons, viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • C07K14/38—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from Aspergillus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C12N15/815—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Abstract

La invencion se relaciona a un banco mutante de micro-organismos diploides que consisten en una poblacion de celulas mutantes en donde por lo menos una celula tiene una mutacion aleatoria que interrumpe la actividad de por lo menos un gen, en donde el micro-organismo es inducible a la forma haploide. La invencion se relaciona ademas a un metodo para usar el banco mutante para identificar los genes que contribuyen a un fenotipo escogido.
MXPA02010064A 2000-04-11 2001-04-11 Bancos mutantes. MXPA02010064A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0008748.6A GB0008748D0 (en) 2000-04-11 2000-04-11 Mutant bank
PCT/GB2001/001626 WO2001077295A1 (en) 2000-04-11 2001-04-11 Mutant bank

Publications (1)

Publication Number Publication Date
MXPA02010064A true MXPA02010064A (es) 2004-08-19

Family

ID=9889560

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02010064A MXPA02010064A (es) 2000-04-11 2001-04-11 Bancos mutantes.

Country Status (11)

Country Link
US (2) US7303868B2 (es)
EP (1) EP1272610A1 (es)
JP (1) JP2003530099A (es)
KR (1) KR100854051B1 (es)
AU (1) AU785214B2 (es)
CA (1) CA2403317A1 (es)
GB (1) GB0008748D0 (es)
MX (1) MXPA02010064A (es)
NO (1) NO20024898L (es)
NZ (1) NZ521451A (es)
WO (1) WO2001077295A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6783985B1 (en) 2000-02-18 2004-08-31 Elitra Pharmaceuticals Inc. Gene disruption methodologies for drug target discovery
US7390620B2 (en) 2001-04-06 2008-06-24 Creatogen Laboratories Gmbh Screening method for anti-microbial drug targets by genome-saturating mutagenesis (GSM)
EP2078727A1 (en) * 2002-03-13 2009-07-15 Bayer CropScience SA Mutagenesis of aspergillus fungi and identification of genes essential for growth
WO2005095975A2 (en) * 2004-04-02 2005-10-13 F2G Ltd Anti-fungal target genes
US20100092954A1 (en) * 2006-08-02 2010-04-15 Bernhard Palsson Method for Determining the Genetic Basis for Physiological Changes in Organisms

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8904762D0 (en) * 1989-03-02 1989-04-12 Glaxo Group Ltd Biological process
WO1994026933A1 (en) 1993-05-13 1994-11-24 The Board Of Trustees Of The Leland Stanford Junior University Genetic footprinting: insertional mutagenesis and genetic selection
NZ296581A (en) 1994-12-09 2000-02-28 Imp College Innovations Ltd A method of identifying genes identified in a microorganisms ability to adapt to changes in its environment
AU6763398A (en) * 1997-03-18 1998-10-12 Millennium Pharmaceuticals, Inc. Aspergillus fumigatus auxotrophs, auxotrophic markers and polynucleotides encoding same
EP0870835A1 (en) 1997-04-07 1998-10-14 Unilever N.V. Agrobacterium mediated transformation of moulds, in particular those belonging to the genus Aspergillus
CA2215870A1 (en) 1997-09-19 1999-03-19 Roger C. Levesque Method for the identification of essential genes and therapeutic targets
US6783985B1 (en) * 2000-02-18 2004-08-31 Elitra Pharmaceuticals Inc. Gene disruption methodologies for drug target discovery

Also Published As

Publication number Publication date
AU785214B2 (en) 2006-11-09
JP2003530099A (ja) 2003-10-14
US20090105088A1 (en) 2009-04-23
CA2403317A1 (en) 2001-10-18
NO20024898L (no) 2002-12-10
US20030129733A1 (en) 2003-07-10
KR20030028463A (ko) 2003-04-08
AU4853001A (en) 2001-10-23
EP1272610A1 (en) 2003-01-08
GB0008748D0 (en) 2000-05-31
KR100854051B1 (ko) 2008-08-26
US7303868B2 (en) 2007-12-04
WO2001077295A1 (en) 2001-10-18
NZ521451A (en) 2005-02-25
NO20024898D0 (no) 2002-10-10

Similar Documents

Publication Publication Date Title
Care et al. The MET3 promoter: a new tool for Candida albicans molecular genetics
Granek et al. Environmental and genetic determinants of colony morphology in yeast
Sumner et al. Phenotypic heterogeneity: differential stress resistance among individual cells of the yeast Saccharomyces cerevisiae
Mortimer et al. Genome renewal: a new phenomenon revealed from a genetic study of 43 strains of Saccharomyces cerevisiae derived from natural fermentation of grape musts
Tenaillon et al. Second-order selection in bacterial evolution: selection acting on mutation and recombination rates in the course of adaptation
Gerstein et al. Ploidy and the causes of genomic evolution
Johzuka et al. Replication fork block protein, Fob1, acts as an rDNA region specific recombinator in S. cerevisiae
James et al. Lager yeasts possess dynamic genomes that undergo rearrangements and gene amplification in response to stress
EP3214177A3 (en) Methods and means for obtaining modified phenotypes
BR0214366A (pt) construção de ácido nucleico recombinante, célula e, métodos para produzir ácido láctico, e para reduzir a atividade de piruvato descarboxilase em uma célula
IN2014DN02484A (es)
CA2311239A1 (en) Methods for defining cell types
Mielich et al. Maize transposable elements Ac/Ds as insertion mutagenesis tools in Candida albicans
MXPA02010064A (es) Bancos mutantes.
Peck et al. The maintenance of sexual reproduction in a structured population
DE69635978D1 (de) Der hefe die flockungsfähigkeit verleihendes gen und genprodukt
WO2003035834A3 (en) Compositions and methods for making mutations in cell lines and animals
NZ523678A (en) The use of mRNA transcripts and variation in transcript levels for the identification of quantitative trait loci (QTL) pertaining to a desired trait within an organism
Sueoka Wide intra-genomic G+ C heterogeneity in human and chicken is mainly due to strand-symmetric directional mutation pressures: dGTP-oxidation and symmetric cytosine-deamination hypotheses
MXPA03004777A (es) Metodo para mapeo de muy alta resolucion de genes y determinacion de redes geneticas entre genes con rasgos fenotipicos subyacentes.
DE60043670D1 (de) Funktionelle gen-array in hefezellen
WO2006032504A3 (en) Method for introducing genetic mutations into plant cells
Xu et al. Fate of a mutant emerging at the initial stage of evolution
Maruyama et al. The minimal eukaryotic ribosomal DNA units in the primitive red alga Cyanidioschyzon merolae
Nag et al. Meiotic recombination between dispersed repeated genes is associated with heteroduplex formation

Legal Events

Date Code Title Description
FG Grant or registration